Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemagglutinin/Neuraminidase protein (HN)-pseudotyped lentivi...
Үндсэн зохиолчид: | Alton, E, Beekman, J, Boyd, A, Brand, J, Carlon, M, Connolly, M, Chan, M, Conlon, S, Davidson, H, Davies, J, Davies, L, Dekkers, J, Doherty, A, Gea-Sorli, S, Gill, D, Griesenbach, U, Hasegawa, M, Higgins, T, Hironaka, T, Hyndman, L, McLachlan, G, Inoue, M, Hyde, S, Innes, J, Maher, T, Moran, C, Meng, C, Paul-Smith, M, Pringle, I, Pytel, K, Rodriguez-Martinez, A, Schmidt, A, Stevenson, B, Sumner-Jones, S, Toshner, R, Tsugumine, S, Wasowicz, M, Zhu, J |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
BMJ Publishing Group
2016
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
-н: Griesenbach, U, зэрэг
Хэвлэсэн: (2016) -
Moving lentiviral-based gene therapy into a first-in-man CF trial
-н: Griesenbach, D, зэрэг
Хэвлэсэн: (2015) -
Towards a first-in-human trial with a pseudotyped lentivirus
-н: Alton, EW, зэрэг
Хэвлэсэн: (2020) -
Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
-н: Hyde, S, зэрэг
Хэвлэсэн: (2015) -
Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
-н: Griesenbach, U, зэрэг
Хэвлэсэн: (2012)